Abstract
Cytochrome bc(1) is a validated drug target in malaria parasites. The spread of Plasmodiumfalciparum strains resistant to multiple antimalarials emphasizes the urgent need for new drugs. We screened in silico the ZINC and MOE databases, using ligand- and structure-based approaches, to identify new leads for development. The most active compound presented an IC(50) value against cultured P. falciparum of 2μM and a docking pose consistent with its activity.
| Original language | English |
|---|---|
| Pages (from-to) | 6302-6308 |
| Number of pages | 7 |
| Journal | Bioorganic and Medicinal Chemistry |
| Volume | 19 |
| Issue number | 21 |
| DOIs | |
| Publication status | Published - 1 Nov 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- malaria
- pharmacophore
- virtual screening
Fingerprint
Dive into the research topics of 'Identification of new antimalarial leads by use of virtual screening against cytochrome bc(1).'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver